AndreaBozzo/ceres-open-data-index huggingface dataset:
National Directory of Drug and Alcohol Abuse Treatment Facilities 2008

The National Directory of Drug and Alcohol Abuse Treatment Programs 2008 lists federal, state, local, and private facilities that provide substance abuse treatment services. The directory includes treatment facilities that are licensed, certified, or otherwise approved for inclusion in the directory by their state substance abuse agencies and that responded to the 2007 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this directory was provided by that facility in response to the 2007 N-SSATS. The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-SSATS annually.
Compound 528686: 1-Butyl-2,4-dimethylbenzene

Chemical compound data from PubChem database. IUPAC Name: 1-butyl-2,4-dimethylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528681: Benzene, 1-ethyl-3-(1-methylpropyl)

Chemical compound data from PubChem database. IUPAC Name: 1-butan-2-yl-3-ethylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Archive: COVID-19 Vaccination and Case Trends by Age Group, United States

</p><p style="margin:0in;vertical-align:baseline;"><strong><em><span style='font-size:15px;font-family:"Calibri",sans-serif;color:black;'>After October 13, 2022, this dataset will no longer be updated as the related CDC COVID Data Tracker site was retired on October 13, 2022.</span></em></strong><span style='font-size:15px;font-family:"Calibri",sans-serif;color:black;'>&nbsp;</span></p>This dataset contains historical trends in vaccinations and cases by age group, at the US national level. Data is stratified by at least one dose and fully vaccinated. Data also represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
2010 CMHS Uniform Reporting System (URS) Output Tables for Wisconsin

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Evaluation of A Passive Back-Support Exoskeleton in Bed-to-Chair Patient Handling Tasks

The objective of this study was to evaluate the effect of a passive back-support exoskeleton on the physical demands of caregivers during bed-to-chair patient handling tasks. Eight participants (5 males and 3 females) performed 4 different patient handling tasks, including 1) lying to sitting, 2) sitting to standing, 3) standing to sitting, and 4) bed to wheelchair transfer with and without the exoskeleton. In certain bed-to-chair patient handling tasks, the exoskeleton (Laevo V2.5) was found to significantly reduce the peak and median values of the hip flexion angles and muscle activities of erector spinae compared to no exoskeleton. The effect of the exoskeleton was task-dependent. The exoskeleton caused a greater reduction of the erector spinae muscle activities of symmetric exertions than the asymmetric exertions. With the exoskeleton, participants adjusted their patient handling strategies by decreasing the hip flexion but increasing the trunk extension. There was a lack of significant changes in the heart rate with the exoskeleton.  The results suggest that back-support exoskeletons could play a role in reducing the muscular demand of the low back during certain bed-to-chair patient handling tasks. However, further research would be needed to fully assess its effectiveness and practicality in improving patient-handling techniques.
Student Weight Status Category Reporting System: 2008-2010

<b>Note: This dataset is no longer updated. Refer to the dataset in the featured content.</b> The Student Weight Status Category Reporting System (SWSCR) collects weight status category data (underweight, healthy weight, overweight or obese, based on BMI-for-age percentile) at school entry (pre-kindergarten or kindergarten) and in grades 2, 4, 7 and 10 for students attending all public schools outside of the five boroughs of New York City.

Because of restrictions in reporting due to the Family Educational Rights and Privacy Act (FERPA) there was wide variation in how much of the student population was represented in the data schools submitted during 2008-2010. Therefore the percentage of the student population represented in the county-level estimates varies from county to county.  This limits researchers' ability to draw absolute conclusions about observed differences in student weight status among counties.

For more information check out http://www.health.ny.gov/prevention/obesity/.
Patent AT-E401023-T1: [Translated] BED WITH ADJUSTMENT MEANS FOR POSITIONING A BARRIER ELEMENT FOR MATTRESSES

The hospital bed comprises a frame with a sleeping plane on which a mattress (3) is placed. It is fitted along one of its longitudinal sides with a barrier (5) able to occupy two end positions. In the first position the barrier is erected vertically with its top located at a higher level than the mattress upper surface. In the second retracted position the barrier top is located at a level lower than that of the mattress upper surface. There are lateral position adjusters (200,200',8) for the barrier in its erected position.
NNDSS - Table II. Invasive Pneumococcal Diseases, Age <5

NNDSS - Table II. Invasive Pneumococcal Diseases, Age <5 - 2017. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
 C.N.M.I.: Commonwealth of Northern Mariana Islands. 

 U: Unavailable. —: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

*Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. 

† Case counts for reporting years 2016 and 2017 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for tuberculosis are displayed in Table IV, which appears quarterly.

§ Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease. This condition was previously named Streptococcus pneumoniae invasive disease and cases were reported to CDC using different event codes to specify whether the cases were drug resistant or in a defined age group, such as <5 years.
Compound 525473: 4,6-Dithianonane

Chemical compound data from PubChem database. IUPAC Name: 1-(propylsulfanylmethylsulfanyl)butane. Molecular Formula: C8H18S2. Molecular Weight: 178.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527524: Propanoic acid, 2-chloro-, tetradecyl ester

Chemical compound data from PubChem database. IUPAC Name: tetradecyl 2-chloropropanoate. Molecular Formula: C17H33ClO2. Molecular Weight: 304.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527079: Tetratriacontane, 2,12-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 2,12-dimethyltetratriacontane. Molecular Formula: C36H74. Molecular Weight: 507.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region

Background
          The number of patients with yeast infection has increased during the last years. Also the variety of species of clinical importance has increased. Correct species identification is often important for efficient therapy, but is currently mostly based on phenotypic features and is sometimes time-consuming and depends largely on the expertise of technicians. Therefore, we evaluated the feasibility of PCR-based amplification of the internally transcribed spacer region 2 (ITS2), followed by fragment size analysis on the ABI Prism 310 for the identification of clinically important yeasts.
        
        
          Results
          A rapid DNA-extraction method, based on simple boiling-freezing was introduced. Of the 26 species tested, 22 could be identified unambiguously by scoring the length of the ITS2-region. No distinction could be made between the species Trichosporon asteroides and T. inkin or between T. mucoides and T. ovoides. The two varieties of Cryptococcus neoformans (var. neoformans and var. gattii) could be differentiated from each other due to a one bp length difference of the ITS2 fragment. The three Cryptococcus laurentii isolates were split into two groups according to their ITS2-fragment lengths, in correspondence with the phylogenetic groups described previously. Since the obtained fragment lengths compare well to those described previously and could be exchanged between two laboratories, an internationally usable library of ITS2 fragment lengths can be constructed.
        
        
          Conclusions
          The existing ITS2 size based library enables identification of most of the clinically important yeast species within 6 hours starting from a single colony and can be easily updated when new species are described. Data can be exchanged between laboratories.
Triplicate IRMA Influenza Calibration Data from 2015

Calibration data (NGS reads in FASTQ) from the IRMA manuscript used to refine variant calling. Data are available in triplicate for various mixture frequencies of two parent donor viruses with known single nucleotide variants. These data were used for calibrating and verifying single nucleotide variant calling data for Illumina sequencing of influenza genomes. See also: https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-016-3030-6
Compound 527532: 2-isopropyl-1H-pyrrole

Chemical compound data from PubChem database. IUPAC Name: 2-propan-2-yl-1H-pyrrole. Molecular Formula: C7H11N. Molecular Weight: 109.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Doravirine, lamivudine, and tenofovir disoproxil fumarate

DELSTRIGO is a prescription medication combining doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg) in an oral tablet. It's used to treat HIV-1 infection in adults and children weighing at least 35 kg, working by inhibiting the virus's ability to replicate. Marketed by Merck Sharp & Dohme LLC since 2018. This information was generated using AI and is provided for informational and research purposes only.
Compound 529116: 4-Quinazolone, 3-butyl-2-ethyl

Chemical compound data from PubChem database. IUPAC Name: 3-butyl-2-ethylquinazolin-4-one. Molecular Formula: C14H18N2O. Molecular Weight: 230.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527679: Butanoic acid, 2-chloro, 2-propynyl ester

Chemical compound data from PubChem database. IUPAC Name: prop-2-ynyl 2-chlorobutanoate. Molecular Formula: C7H9ClO2. Molecular Weight: 160.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 CMHS Uniform Reporting System (URS) Output Tables for Iowa

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Non-Regulatory Guidance: Ensuring Educational Stability for Children in Foster Care

U.S. Departments of Education (ED) and Health and Human Services (HHS) provided this joint guidance as a key tool for educational and child welfare agencies to use as they embark on establishing new partnerships and implementing the new provisions of the law. In addition to clarifying the statutory requirements, the guidance provides recommendations for SEAs, LEAs, and CWAs and highlights promising practices from the field for agencies to consider as they move toward implementation by December 10, 2016.

Dear Colleague letters on foster care guidance and timelines are also included below.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528650: 3-Hydroxytetradecanedioic acid, tri-TMS

Chemical compound data from PubChem database. IUPAC Name: bis(trimethylsilyl) 3-trimethylsilyloxytetradecanedioate. Molecular Formula: C23H50O5Si3. Molecular Weight: 490.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Treatment Episode Data Set (TEDS): 1994-1999, National Admissions to Substance Abuse Treatment Services

This report presents data from the Treatment Episode Data Set (TEDS) for 1999, and trend data for 1994 to 1999. The report provides information on the demographic and substance abuse characteristics of people aged 12 and older admitted to treatment for abuse of alcohol and/or drugs in facilities that report to individual state administrative data systems.
Patent AT-E400283-T1: [Translated] REOVIRUS FOR THE TREATMENT OF CELLULAR PROLIFERATIVE DISEASES

Chemical patent from PubChem database. Patent Number: AT-E400283-T1. Title: Chemical Synthesis Method. Filing Date: 2000-01-24. Inventors: Patel, Amit, Jones, Michael. Abstract: A novel method for chemical synthesis is provided, utilizing specific catalysts and reaction conditions to achieve selective transformations with high... IPC Classifications: C08G, C08K, A61K. This patent covers 23 claims related to 2 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Compound 526900: Ethanol, 2-2-(pentyloxy)ethoxy-

Chemical compound data from PubChem database. IUPAC Name: 2-(2-pentoxyethoxy)ethanol. Molecular Formula: C9H20O3. Molecular Weight: 176.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525659: p-Bromobenzylidene-(4-bromophenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: N,1-bis(4-bromophenyl)methanimine. Molecular Formula: C13H9Br2N. Molecular Weight: 339.02. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Morphological, histochemical, and interstitial pressure changes in the tibialis anterior muscle before and after aortofemoral bypass in patients with peripheral arterial occlusive disease

Background
          Morphological and electrophysiological studies of ischemic muscles in peripheral arterial disease disclosed evidence of denervation and fibre atrophy. The purpose of the present study is to describe morphological changes in ischemic muscles before and after reperfusion surgery in patients with peripheral occlusive arterial disease, and to provide an insight into the effect of reperfusion on the histochemistry of the reperfused muscle.
        
        
          Methods
          Muscle biopsies were obtained from the tibialis anterior of 9 patients with chronic peripheral arterial occlusive disease of the lower extremities, before and after aortofemoral bypass, in order to evaluate the extent and type of muscle fibre changes during ischemia and after revascularization. Fibre type content and muscle fibre areas were quantified using standard histological and histochemical methods and morphometric analysis. Each patient underwent concentric needle electromyography, nerve conduction velocity studies, and interstitial pressure measurements.
        
        
          Results
          Preoperatively all patients showed muscle fibre atrophy of both types, type II fibre area being more affected. The mean fibre cross sectional area of type I was 3,745 μm2 and of type II 4,654 μm2 . Fibre-type grouping, great variation in fibre size and angular fibres were indicative of chronic dennervation-reinnervation, in the absence of any clinical evidence of a neuropathic process. Seven days after the reperfusion the areas of both fibre types were even more reduced, being 3,086 μm2 for type I and 4,009 μm2 for type II, the proportion of type I fibres, and the interstitial pressure of tibialis anterior were increased.
        
        
          Conclusions
          The findings suggest that chronic ischemia of the leg muscles causes compensatory histochemical changes in muscle fibres resulting from muscle hypoxia, and chronic dennervation-reinnervation changes, resulting possibly from ischemic neuropathy. Reperfusion seems to bring the oxidative capacity of the previously ischemic muscle closer to normal.
Nursing Home Cost Report (RHCF): 2019

The Nursing Home Cost Report (RHCF) is a uniform report completed by New York nursing homes to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations (Part 86-2.2), nursing homes are required to file financial and statistical data with DOH annually. The data filed is part of the cost report and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends.
NSDUH 2021 Methodological Resource Book (MRB)

Use this collection to provide context for estimates from the National Survey on Drug Use and Health (NSDUH). This collection includes materials used to conduct the survey, reports on how the survey was conducted, and reports on how the data were processed. The Statistical Inference Report details how the data were analyzed for reports and tables, which may be useful for data users looking to do their own analysis.New items are added to the collection as they become available, so resources published in a previous MRB may not yet be available for 2021. However, there are generally few changes from year to year, and a report from a previous year may have the information you are looking for.
Compound 529792: Formic acid, 3,5-bis-(trifluoromethyl)phenylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: [3,5-bis(trifluoromethyl)phenyl]methyl formate. Molecular Formula: C10H6F6O2. Molecular Weight: 272.14. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528886: Butalbital M (OH)

Chemical compound data from PubChem database. IUPAC Name: 5-ethyl-5-(2-hydroxybutan-2-yl)-1,3-diazinane-2,4,6-trione. Molecular Formula: C10H16N2O4. Molecular Weight: 228.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Evaluation of differential gene expression during behavioral development in the honeybee using microarrays and northern blots

Background
          The honeybee (Apis mellifera) has been used with great success in a variety of behavioral studies. The lack of genomic tools in this species has, however, hampered efforts to provide genome-based explanations for behavioral data. We have combined the power of DNA arrays and the availability of distinct behavioral stages in honeybees to explore the dynamics of gene expression during adult development in this insect. In addition, we used caffeine treatment, a procedure that accelerates learning abilities in honeybees, to examine changes in gene expression underlying drug-induced behavioral modifications.
        
        
          Results
          Spotted microarrays containing several thousand cDNAs were interrogated with RNAs extracted from newly emerged worker bees, experienced foragers and caffeine-treated bees. Thirty-six differentially expressed cDNAs were verified by northern blot hybridization and characterized in silico by sequencing and database searches. Experienced foragers overexpressed royal jelly proteins, a putative imaginal disc growth factor, a transcriptional regulator (Stck) and several enzymes, including α-glucosidases, aminopeptidases and glucose dehydrogenase. Naive workers showed increased expression of members of the SPARC and lectin families, heat-shock cognate proteins and several proteins related to RNA translation and mitochondrial function. A number of novel genes overexpressed in both naive and experienced bees, and genes induced by caffeine, have also been identified.
        
        
          Conclusions
          We have shown the usefulness of this transcriptome-based approach for gene discovery, in particular in the context of the efficacy of drug treatment, in a model organism in which routine genetic techniques cannot be applied easily.
Compound 525454: 3-Methyl-4-thianonane

Chemical compound data from PubChem database. IUPAC Name: 1-butan-2-ylsulfanylpentane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.